Cargando…
An important call: Suggestion of using IL-10 as therapeutic agent for COVID-19 with ARDS and other complications
The global coronavirus disease 2019 (COVID-19) pandemic has a detrimental impact on public health. COVID-19 usually manifests as pneumonia, which can progress into acute respiratory distress syndrome (ARDS) related to uncontrolled TH17 immune reaction. Currently, there is no effective therapeutic ag...
Autores principales: | Shih, Li-Jane, Yang, Chun-Chun, Liao, Min-Tser, Lu, Kuo-Cheng, Hu, Wan-Chung, Lin, Chih-Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026935/ https://www.ncbi.nlm.nih.gov/pubmed/36914565 http://dx.doi.org/10.1080/21505594.2023.2190650 |
Ejemplares similares
-
Right ventricule-specific therapies in ARDS: other vasodilating agents to be considered
por: Ymeraj, Senada, et al.
Publicado: (2023) -
Tuberculosis complicated by ARDS
por: Arevalo-Lorido, J. C., et al.
Publicado: (2001) -
Scrub Typhus Complicated by ARDS, Myocarditis, and Encephalitis Imported to Oman from Nepal
por: Mahdi, Asmaa Sabr, et al.
Publicado: (2019) -
Pulmonary infections complicating ARDS
por: Luyt, Charles-Edouard, et al.
Publicado: (2020) -
Cardiovascular Subphenotypes in ARDS: Diagnostic and Therapeutic Implications and Overlap with Other ARDS Subphenotypes
por: Chotalia, Minesh, et al.
Publicado: (2023)